ORMP
Oramed Pharmaceuticals Inc
Price:  
2.19 
USD
Volume:  
53,197.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

ORMP WACC - Weighted Average Cost of Capital

The WACC of Oramed Pharmaceuticals Inc (ORMP) is 5.8%.

The Cost of Equity of Oramed Pharmaceuticals Inc (ORMP) is 6.20%.
The Cost of Debt of Oramed Pharmaceuticals Inc (ORMP) is 7.00%.

Range Selected
Cost of equity 5.40% - 7.00% 6.20%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 7.00% - 7.00% 7.00%
WACC 5.3% - 6.3% 5.8%
WACC

ORMP WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.34 0.38
Additional risk adjustments 0.0% 0.5%
Cost of equity 5.40% 7.00%
Tax rate 26.20% 27.00%
Debt/Equity ratio 0.56 0.56
Cost of debt 7.00% 7.00%
After-tax WACC 5.3% 6.3%
Selected WACC 5.8%